$6.28B
$13,000
0.01% of portfolio
2,400
Q4 2024
Reduced 11.11%
$2.31B
$17,000
0.01% of portfolio
3,600
Q4 2024
Reduced 12.2%
$8.23B
$37,000
0.01% of portfolio
723
Q2 2023
Reduced 44.08%
$10.9B
$36,000
0.01% of portfolio
1,711
Q1 2023
Reduced 5.52%
$184B
$29,000
0.01% of portfolio
1,000
Q4 2024
Reduced 9.09%
$20.9B
$34,000
0.01% of portfolio
600
Q4 2024
Reduced 14.29%
$14.4B
$17,000
0.01% of portfolio
400
Q4 2024
Reduced 20.0%
$14.7B
$20,000
0.01% of portfolio
1,600
Q4 2024
Reduced 11.11%
$10.3B
$19,000
0.01% of portfolio
1,400
Q4 2024
Reduced 12.5%
$21.5B
$22,000
0.01% of portfolio
4,300
Q4 2024
Reduced 12.24%
$2.59B
$17,000
0.01% of portfolio
885
Q1 2023
Reduced 5.35%
$7.03B
$25,000
0.01% of portfolio
2,400
Q2 2024
Reduced 94.79%
$7.33B
$33,000
0.01% of portfolio
2,400
Q4 2024
Reduced 11.11%
$31.4B
$31,000
0.01% of portfolio
1,500
Q4 2024
Added 400.0%
$43.1B
$29,000
0.01% of portfolio
900
Q4 2024
Reduced 10.0%
$28.9B
$16,000
0.01% of portfolio
1,200
Q4 2024
Reduced 14.29%
$39.3B
$17,000
0.01% of portfolio
1,500
Q4 2024
Reduced 11.76%
$24.3B
$18,000
0.01% of portfolio
700
Q4 2024
Reduced 12.5%
$29.5B
$33,000
0.01% of portfolio
7,500
Q4 2024
Reduced 11.76%
$99.3B
$16,000
0.01% of portfolio
300
Q3 2023
New
$27.1B
$29,000
0.01% of portfolio
2,300
Q4 2024
Reduced 11.54%
$19.8B
$20,000
0.01% of portfolio
2,550
Q4 2024
Reduced 13.56%
$46.2B
$33,000
0.01% of portfolio
2,500
Q4 2024
Reduced 10.71%
$24.2B
$29,000
0.01% of portfolio
6,100
Q4 2024
Reduced 11.59%
$7.66B
$32,000
0.01% of portfolio
176
Q4 2022
Reduced 93.66%
$14.4B
$29,000
0.01% of portfolio
3,100
Q4 2024
Reduced 11.43%
$392M
$16,000
0.01% of portfolio
1,456
Q1 2023
Reduced 6.43%
$0
$16,000
0.01% of portfolio
1,300
Q4 2024
Reduced 13.33%
$90.3B
$20,000
0.01% of portfolio
700
Q4 2024
Reduced 12.5%
$88.6B
$28,000
0.01% of portfolio
220
Q2 2024
Added 10.0%
$34.8B
$28,000
0.01% of portfolio
400
Q3 2024
Reduced 20.0%
$36.7B
$33,000
0.01% of portfolio
17,935
Q2 2023
Reduced 43.55%
$46.2B
$22,000
0.01% of portfolio
800
Q4 2024
Reduced 11.11%
$0
$21,000
0.01% of portfolio
1,200
Q4 2024
Reduced 14.29%
$229B
$34,000
0.01% of portfolio
700
Q4 2024
Reduced 12.5%
$6.15B
$28,000
0.01% of portfolio
415
Q4 2024
Reduced 78.33%
$58.6B
$30,000
0.01% of portfolio
900
Q4 2024
Reduced 10.0%
$48.9B
$30,000
0.01% of portfolio
2,300
Q4 2024
Reduced 11.54%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 33.13%
Seven & I Holdings CO LTD
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 43.04%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 92.46%
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 44.59%
$97.5B
$6,000
0.0% of portfolio
224
Q4 2023
Reduced 43.43%
Santen Pharmaceutical CO LTD
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2023
Reduced 42.6%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 15.29%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 2.78%
-
$0
0.0% of portfolio
-
Q4 2024
New